|
Recurrent Small Intestine Cancer
Current Clinical Trials
Standard treatment options:
- For metastatic adenocarcinoma or leiomyosarcoma:
- No standard effective chemotherapy exists for patients with recurrent metastatic
adenocarcinoma or leiomyosarcoma of the small intestine. These types of patients
should be considered candidates for clinical trials evaluating the use of new
anticancer drugs or biologicals in phase I and phase II trials.
- For locally recurrent disease:
- Surgery.
- Palliative radiation therapy.
- Palliative chemotherapy.
- Clinical trials evaluating ways of improving local control, such as the use
of radiation therapy with radiosensitizers with or without systemic
chemotherapy.
Current Clinical Trials
Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with recurrent small intestine cancer. The list of clinical trials can be further narrowed by location, drug, intervention, and other criteria.
General information about clinical trials is also available from the NCI Web site.
Back to Top
< Previous Section | Next Section > |
